Evidence map›Paper›PMID 34725945›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology2022

Synthetic cells in biomedical applications.

Wakana Sato, Tomasz Zajkowski, Felix Moser, Katarzyna P Adamala

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Review
  2. Let There be Light! Light as an Engine and Regulator in Synthetic Cells.Angewandte Chemie (International ed. in English) · 2026
    Review
  3. Review
  4. Review
  5. Rethinking governance of synthetic cells.Frontiers in bioengineering and biotechnology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Building a Synthetic Cell Together.Nature communications · 2025
    Review
  10. Thermally Driven Dynamic Behaviors in Polymeric Vesicles.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Nucleated synthetic cells with genetically driven intercompartment communication.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Artificial Neutrophils Against Vascular Graft Infection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  18. Review
  19. Review
  20. Present and future of synthetic cell development.Nature reviews. Molecular cell biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wakana SatoDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-5997-4438
Tomasz ZajkowskiCentre of New Technologies, University of Warsaw, Warsaw, Poland.ORCID 0000-0001-9433-6071
Felix MoserSynlife, Inc., Cambridge, Massachusetts, USA.
Katarzyna P AdamalaDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0003-1066-7207

Funding

RNA Scaffolds for Cell Specific Multiplexed Neural ObservationR01MH114031 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BOYDEN, EDWARD S. · 2017 to 2020
$2.8M
NIMH NIH HHS R01 MH114031
6 · The paper itself

Abstract

Synthetic cells are engineered vesicles that can mimic one or more salient features of life. These features include directed localization, sense-and-respond behavior, gene expression, metabolism, and high stability. In nanomedicine, many of these features are desirable capabilities of drug delivery vehicles but are difficult to engineer. In this focus article, we discuss where synthetic cells offer unique advantages over nanoparticle and living cell therapies. We review progress in the engineering of the above life-like behaviors and how they are deployed in nanomedicine. Finally, we assess key challenges synthetic cells face before being deployed as drugs and suggest ways to overcome these challenges. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Biology-Inspired Nanomaterials > Lipid-Based Structures.

Indexed as

Artificial CellsNanoparticlesNanostructuresDrug Delivery SystemsNanomedicinesynthetic biologysynthetic cells

Identifiers

PMID34725945
PMCPMC8918002

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.